Hypermarcas S/A ADR | Cash Flow

Fiscal year is January-December. All values BRL Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
313
482
681
1,613
998
1,225
Depreciation, Depletion & Amortization
105
110
107
72
77
89
Other Funds
-
45
245
67
326
3
Funds from Operations
569
718
135
673
1,165
1,317
Changes in Working Capital
266
405
472
212
351
291
Net Operating Cash Flow
303
312
336
462
813
1,026
Capital Expenditures
242
204
257
214
212
Sale of Fixed Assets & Businesses
28
156
1,739
2,505
765
Net Investing Cash Flow
122
68
1,597
2,450
659
Cash Dividends Paid - Total
102
-
-
316
410
Issuance/Reduction of Debt, Net
701
345
581
-
-
Net Financing Cash Flow
759
291
334
4,320
1,298
Net Change in Cash
578
671
926
1,408
174
Free Cash Flow
79
133
553
285
656
Net Assets from Acquisitions
-
-
4
19
-
Other Sources
92
116
119
177
106
Change in Capital Stock
43
10
2
81
961

About Hypermarcas

View Profile
Address
Rua Nova Cidade, Nº 404
São Paulo Sao Paulo 04547
Brazil
Employees -
Website http://www.hyperapharma.com.br
Updated 07/08/2019
Hypera SA is a pharmaceutical company which manufactures and distributes medical and cosmetics products. It offers business through Prescription Products, Consumer Health, and Similar and Generic segments. The Prescription Products segment deals with therapeutic medicines and dermocosmetics.